Oncologist Tiseo: "New Therapeutic Combination for Microcytoma, Important Step Forward" - Five Columns Magazine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
The result of this study is particularly important. Microcytoma, an aggressive form of lung cancer, could benefit from a significant increase in survival thanks to a new therapeutic strategy. According to the results presented today at the Presidential Symposium of the Congress of the European Society of Medical Oncology (Esmo) in Madrid, treatment with... Continue reading L'articolo Oncologisto Tiseo: "New therapeutic combination for microcytom…
Giornale Radio
"The result of this study is particularly important. Microcytoma, an aggressive form of lung cancer, could benefit from a significant increase in survival thanks to a new therapeutic strategy. According to the results presented today at the Presidential Symposium of the Congress of the European Society of Medical Oncology (Esmo) in Madrid, treatment with tarlatamab in combination with durvalumab-based immunotherapy resulted in median survival of…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
